Elixinol Wellness trading halt request details

Elixinol Wellness Limited (ASX:EXL) has requested a trading halt in its securities as per ASX Listing Rule 17.1. The halt is pending the release of an announcement by the company about a potential capital raising and acquisition. The trading halt is expected to remain in place until the earlier of the company making an announcement regarding the permitted purpose or the commencement of trading on Thursday, 3 October 2024.

Elixinol Wellness trading halt announcement

The company has requested the trading halt in order to provide the market with information about a potential capital raising and acquisition. The announcement is expected to be made before the commencement of normal trading on Thursday, 3 October 2024. The Board of Directors of Elixinol Wellness Limited has authorized this request, and the company secretary, Mrs. Melanie Leydin, has confirmed the request.

Elixinol Wellness trading halt summary

Elixinol Wellness Limited (ASX:EXL) has requested a trading halt to release an announcement regarding a potential capital raising and acquisition. The company aims to provide the market with necessary information before the commencement of normal trading on Thursday, 3 October 2024. This move reflects the company's strategic considerations and its commitment to transparent communication with the market.